Maruti Suzuki, HUL, TCS in focus

Maruti Suzuki India would re-start production of vehicles at its Manesar plant from the 12 May 2020. All activities would be carried out strictly in accordance with the Government regulations and guidelines and observing the company's own concern for the highest standards of safety.

Shares of Hindustan Unilever (HUL) will be in focus. GlaxoSmithKline Pte and Horlicks reportedly plan to sell 5.69% stake in HUL via block deals at a price band Rs 1,850 - 1,950 per share for $3.3-3.5 billion. GSK is expected to sell the stake today, 7 May 2020.

Tata Consultancy Services (TCS) announced that Continental Bank in the US has selected TCS BaNCS Cloud for banking to digitally transform its business.

Dr. Reddy's Laboratories announced approval of ELYXYB (celecoxib oral solution 25 mg/mL) by the U.S. Food and Drug Administration (USFDA). ELYXYB (previously known as DFN-15) is indicated for the acute treatment of migraine with or without aura in adults. ELYXYB is the latest product emerging from Dr. Reddy's portfolio of successful acute migraine treatments. The company is working to commercialize this product through partners.

Adani Transmission said that the board of directors will on Saturday, 9 May 2020 consider to recommend to raise funds by issue of Equity Shares / Convertible Bonds through Qualified Institutional Placement [QIP] / GDR / ADR / FCCBs / FCEBs / Convertible Securities.

Department of Investment and Public Asset Management (DIPAM), Ministry of Finance, Govt of India has intimated regarding the appointment of Trilegal as Legal Advisors and IDBI Capital Market & Securities Ltd, SBI Capital Markets Ltd & Yes Securities (India) Limited as Merchant Bankers & Selling Brokers for the disinvestment of 15% Paid up equity Capital of Hindustan Aeronautics.

Yes Bank's total income rose 44.4% to Rs 12,115.53 crore in Q4 March 2020 over the corresponding period last year. The bank reported loss from ordinary activities after tax of Rs 3,668 crore in Q4 March 2020 as compared to net loss of Rs 1,507 crore in Q4 March 2019. The result was announced after market hours on Wednesday (6 May 2020).

Powered by Capital Market - Live News